US Stem Cell Inc (USRM)

[Dragon Lady]

USRM-a-CON: NOW RATED "SHELL RISK" OTC MARKETS :)))

Seems sketchY

THAT is putting it EXTREMELY "mildly" to say the least LMAO !!!

This is one of the BIGGEST SCAMS and CON-JOB FRAUDS in OTC history - the ultimate DILUTION MILL that also "managed" to BUTCHER un-told numbers of "Patients" and then get sued by the FDA-DOJ and lost big big bigly.....

LITERAL 99.99999% LOSSES TO THE COMMON SHARES as the "CEO" clown was paying HIMSELF and his FAKE PhD side-kick Kristin Comella like freaking royalty...WTF !!

ALL while printing endless DILUTION MILL SHARES and PAYING INSIDERS AS IF THESE ASS CLOWN LOSERS WERE RUNNING A FORTUNE 500 real life "COMPANY" or some bullshit....

THE CEO aka ONE MAN SHOW is as dirty as a roadside gas station toilet seat if you ask me - the dude has STIFFED more people out of their money than some clown who knocks off liquor stores and sells "GENUINE $1K ARMANI SUITS" out of a plain white panel van in the back alleys of shit hole New Jersey Bwaaaa ha ha ha !

OTC JUST SLAPPED THIS POS SMOKE MACHINE WITH "SHELL RISK" which tells me their prior "SEC CORRESPONDENCE" is a real-life "SEC FORMAL INVESTIGATION" which is likely the ON-GOING INVESTIGATION THAT NEVER ENDED after FDA-DOJ-a-CON and the fallout of that total crime scene.....

https://www.otcmarkets.com/stock/USRM/disclosure

"Shell Risk IconShell Risk

Shell Risk

The Shell Risk designation indicates that a company displays characteristics common to Shell Companies. This designation is made at OTC Markets’ sole and absolute discretion based on an analysis of the company’s annual financial data and may differ from issuers’ self-reported shell classifications in their own public filings. Our analysis evaluates asset composition, operational expenditures, and income related metrics. No action is required by a company to perform the evaluation other than publishing current annual financial information.

In limited circumstances, OTC Markets will consider removal of a company’s shell risk designation upon written request by a company. Please be advised that such requests will only be considered when there has been a material change in financial condition since the most recent fiscal year-end that is reflected in publicly available interim financial statements. Examples include a material increase in asset composition or operating revenues with related financial disclosure as a result of an acquisition or change in control transaction.
"

"SHELL COMPANY" =
CONDUCTS NO ACTUAL OR REAL "BUSINESS" and is merely a "vehicle" to PRINT AND SELL DILUTION SHARES to penny marks and dupes and ENRICH A TINY FEW INSIDERS and often then SELL THE SHELL to further the insiders enrichment OR use the shell to RUN A NEW CON...aka the RE-SPIN THE SHELL "scam" sooooo common on the old OTC but CRACKED-DOWN ON since the 211 changes and operation "SHELL EXPEL" massive regulatory revisions of a few short yrs ago to bust-down these kinds of perpetual con job scams....

THEE END - this one is just about ready to be READ THE LAST RIGHTS AND BE BURNED ON THE FUNERAL PYRE.....:)))

https://www.bizjournals.com/southflorida/stories/2010/09/20/daily51.html

Ole Miguel Mike Michael Tomas and the ASTRI GROUP "brothers in prison" infamy LMAO... (Tomas CHANGED THE NAME OF "BIOHEART" this POS penny stock con-job...to "U.S. Stem Cell" in Dec 2015 and then then then DID A MASSIVE 1 for 1000 REVERSE SPLIT AND DILUTED THE SHIT OUT OF IT ALLLL OVER AGAIN !!!) :

QUOTE:

"Jailed de Céspedes brothers named in foreclosure

Carlos de Céspedes


By Brian Bandell –
Sep 24, 2010 Updated Sep 24, 2010, 3:34pm EDT

A foreclosure lawsuit targeting the Las Vegas Cuban Cuisine restaurant in Doral involves the jailed de Céspedes brothers and the current CEO and president of Bioheart (OTCBB: BHRT).

MUNB Loan Holdings, an affiliate of Bank of New York Mellon, filed the foreclosure lawsuit Sept. 16 against Doral Land Holdings, Chispa Restaurant-Doral, Jorge de Céspedes, Carlos de Céspedes, the Astri Group and El Doral/Las Vegas Cuban Cuisine, according to Miami-Dade County Circuit Court records.

The 12,163-square-foot building, at 11500 N.W. 41st St., once housed Chispa, which was owned by the de Céspedes brothers. They are best known for founding Pharmed, which at one time was one of the largest private health care companies in South Florida.

The de Céspedes brothers were charged with fraud and tax evasion in 2008 for defrauding Kendall Regional Medical Center out of millions of dollars through faked purchase orders. After pleading guilty, they were sentenced to nine years in prison and ordered to pay $6.9 million in restitution.

Pharmed filed Chapter 11 bankruptcy in October 2007 and was liquidated.

In September 2005, Mellon United National Bank gave a $2.6 million mortgage on the restaurant to Astri Group, which at the time was managed by the de Céspedes brothers and Miguel “Mike” Tomas, who later became the CEO and president of Sunrise-based Bioheart. All three men signed the mortgage as the managing members of Astri Group.

Click here to see the signature page on that mortgage.

Several months after Pharmed went under, the de Céspedes brothers had Astri Group transfer the Doral restaurant to Doral Land Holdings, which was solely managed by Tomas.

When the biotechnology company named Tomas its CEO and president in June, it said he was the president of Astri Group, which has held a stake in Bioheart since 2001. Florida records list Tomas as the only manager of Astri Group, and lists Astri Group as the managing member of Doral Land Holdings.

After the property changed hands through a quit-claim deed, Mellon United allowed the mortgage to transfer to Doral Land Holdings, and even increased the loan to $3.1 million in 2008. However, the de Céspedes brothers remained the guarantors.

Las Vegas Cuban Cuisine operates there, but Tomas is not listed in state records as being among the restaurant’s managers. The foreclosure lawsuit does not name Tomas.

A call to Tomas at Bioheart was not immediately returned. Although its stem cell treatments for cardiac patients have shown some promising results, the company is short on cash and recently disclosed that it was in default on a line of credit with Bank of America.

Miami attorney Rachel Camber, who represents MUNB in the lawsuit, declined to comment.
"

https://www.sun-sentinel.com/business/fl-bz-us-stem-cell-loses-appeal-of-shutdown-20210603-bft7txqtkvb5hc5lzgemzh7niu-story.html

https://www.reuters.com/legal/litigation/unproven-stem-cell-therapy-subject-fda-regulation-11th-circ-2021-06-02/